Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Assets (2016 - 2025)

Historic Return on Assets for CorMedix (CRMD) over the last 12 years, with Q3 2025 value amounting to 0.32%.

  • CorMedix's Return on Assets rose 9300.0% to 0.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.32%, marking a year-over-year increase of 9300.0%. This contributed to the annual value of 0.45% for FY2022, which is 200.0% up from last year.
  • CorMedix's Return on Assets amounted to 0.32% in Q3 2025, which was up 9300.0% from 0.25% recorded in Q2 2025.
  • CorMedix's Return on Assets' 5-year high stood at 0.32% during Q3 2025, with a 5-year trough of 0.79% in Q2 2024.
  • In the last 5 years, CorMedix's Return on Assets had a median value of 0.43% in 2022 and averaged 0.35%.
  • As far as peak fluctuations go, CorMedix's Return on Assets tumbled by -1700bps in 2022, and later surged by 10400bps in 2025.
  • Over the past 5 years, CorMedix's Return on Assets (Quarter) stood at 0.39% in 2021, then dropped by -22bps to 0.48% in 2022, then fell by -12bps to 0.54% in 2023, then surged by 66bps to 0.18% in 2024, then surged by 277bps to 0.32% in 2025.
  • Its last three reported values are 0.32% in Q3 2025, 0.25% for Q2 2025, and 0.13% during Q1 2025.